OnePlus Ace 2 Smartphone and Genshin Impact's Xiangling Collaborate in New Release, Priced at $538 shanghaiist.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from shanghaiist.com Daily Mail and Mail on Sunday newspapers.
Chinese producers and pharmacies are beefing up supplies after cold-related drugs such as oseltamivir were sold quickly in many parts of the country in the wake of the outbreak of H1N1, a seasonal flu that often comes in late winter and the beginning of spring.
Many Chinese pharmaceutical companies are operating at full capacity to meet rocketing demand for cold and fever medicines, and thanks to various measures taken by the government and firms, the shortages are easing, according to industry insiders on Tuesday.
On March 12, the State Food and Drug Administration issued a notice that the first batch of 5 new crown antigen self-test products were officially launched. A reporter from China Securities Journal learned on March 13 that Meituan Buying has launched a self-testing product for COVID-19. At the same time, chain pharmacies such as the People's Pharmacy and a number of pharmaceutical e-commerce